Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Summary of Stock Option Activity

Stock option activity for the three months ended March 31, 2024 was as follows:

	Stock Options
	Number of Stock Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance as of December 31, 2023		8,175,088		$	8.64		7.22	$	31,135
Granted		346,935			12.34
Exercised		(493,608	)		6.64
Cancelled		(140,551	)		9.29
Balance as of March 31, 2024		7,887,864		$	8.92		7.19	$	33,697
Vested and exercisable		4,882,281		$	8.53		6.48	$	22,848

Summary of RSU Activity

RSU activity for the three months ended March 31, 2024 was as follows:

	Restricted Stock Units
	Number of Restricted Stock Units Outstanding			Weighted Average Grant Date Fair Value
Balance as of December 31, 2023		8,919,024		$	8.98
Granted		4,821,233			12.35
Released		(1,737,736	)		9.04
Cancelled		(286,347	)		9.24
Balance as of March 31, 2024		11,716,174		$	10.36

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense from stock options and RSUs, reduced for actual forfeitures, was included in the following line items in the accompanying consolidated statement of operations:

	Three Months Ended March 31,
	2024		2023
Cost of revenues	$	1,197	$	1,017
Sales and marketing		1,098		1,135
Research and development		3,658		2,219
General and administrative		4,813		4,290
Total	$	10,766	$	8,661

Schedule of Employee Stock Purchase Plan Expense

Total ESPP expense recorded in the Company's consolidated statements of operations was as follows:

	Three Months Ended March 31,
	2024		2023
ESPP expense	$	193	$	270